From: Total and caspase-cleaved cytokeratin 18 in chronic cholecystitis: A prospective study
Group A | Group B | Two-tailed p | ||
---|---|---|---|---|
Serum | Caspase-cleaved CK18 (U/l) | 292.550 ± 192.121 | 207.356 ± 139.373 | 0.231 |
Total CK18 (U/l) | 579.100 ± 372.171 | 431.286 ± 183.045 | 0.257 | |
Ratio: Caspase-cleaved CK18/total CK18 | 0.581 ± 0.173 | 0.583 ± 0.503 | 0.130 | |
Bile | Caspase-cleaved CK18 (U/l) | 963.280 ± 308.69 | 1490.571 ± 1045.862 | 0.186 |
Total CK18 (U/l) | 3292.360 ± 3041.213 | 5305.875 ± 2177.843 | 0.160 | |
Ratio: Caspase-cleaved CK18/total CK18 | 1.319 ± 2.288 | 0.598 ± 1.083 | 0.770 |